share_log

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

艾伯維公司 | 144:擬議出售證券
美股SEC公告 ·  03/20 19:33
Moomoo AI 已提取核心訊息
AbbVie Inc. officer Nicholas Donoghoe is set to sell 21,082 common shares of the company, with an aggregate market value of approximately $3.72 million, on March 20, 2024. The shares were acquired as performance shares directly from the issuer on February 28, 2024, as part of compensation. There is no reportable history of securities sold by Donoghoe in the past three months prior to this notice dated March 20, 2024.
AbbVie Inc. officer Nicholas Donoghoe is set to sell 21,082 common shares of the company, with an aggregate market value of approximately $3.72 million, on March 20, 2024. The shares were acquired as performance shares directly from the issuer on February 28, 2024, as part of compensation. There is no reportable history of securities sold by Donoghoe in the past three months prior to this notice dated March 20, 2024.
艾伯維公司高管尼古拉斯·多諾霍定於2024年3月20日出售該公司的21,082股普通股,總市值約爲372萬美元。作爲薪酬的一部分,這些股票於2024年2月28日作爲績效股直接從發行人手中收購。在2024年3月20日發佈本通知之前的過去三個月中,沒有可申報的Donoghoe出售證券的歷史記錄。
艾伯維公司高管尼古拉斯·多諾霍定於2024年3月20日出售該公司的21,082股普通股,總市值約爲372萬美元。作爲薪酬的一部分,這些股票於2024年2月28日作爲績效股直接從發行人手中收購。在2024年3月20日發佈本通知之前的過去三個月中,沒有可申報的Donoghoe出售證券的歷史記錄。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息